rituximab and recombinant human hyaluronidase

rituximab and recombinant human hyaluronidase
Trade Name Rituxan Sc
Orphan Indication Follicular lymphoma
USA Market Approval USA
USA Designation Date 2016-08-22 00:00:00
Sponsor Genentech, Inc.;1 DNA Way;South San Francisco, California, 94080
Related Access Program
Kite, A Gilead Company – Relapsed/Refractory Transformed Follicular Lymphoma Kite Pharma, Inc. – Relapsed/Refractory Transformed Follicular Lymphoma Kite Pharma, Inc. – Relapsed/Refractory Transplant Ineligible Transformed Follicular Lymphoma